Cargando…

What should we focus on before preimplantation genetic diagnosis/screening?

INTRODUCTION: Preimplantation genetic diagnosis/screening (PGD/PGS) can effectively detect chromosomal abnormalities in an embryo but only if an embryo is available. However, not all couples can obtain an embryo that is available for testing. The purpose of this study was to identify factors which m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhong, Zhao, Xiaoming, Xu, Bing, Yao, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111346/
https://www.ncbi.nlm.nih.gov/pubmed/30154896
http://dx.doi.org/10.5114/aoms.2018.72790
_version_ 1783350639721447424
author Zheng, Zhong
Zhao, Xiaoming
Xu, Bing
Yao, Ning
author_facet Zheng, Zhong
Zhao, Xiaoming
Xu, Bing
Yao, Ning
author_sort Zheng, Zhong
collection PubMed
description INTRODUCTION: Preimplantation genetic diagnosis/screening (PGD/PGS) can effectively detect chromosomal abnormalities in an embryo but only if an embryo is available. However, not all couples can obtain an embryo that is available for testing. The purpose of this study was to identify factors which might affect the formation of PGD/PGS embryos to predict the possibility of obtaining embryos that could be detected. MATERIAL AND METHODS: In a retrospective study, we included all couples who underwent PGD/PGS at our center from January 2015 to December 2016. We compared these patients according to the non-blastocyst group and the blastocyst group. RESULTS: There were 302 couples who had blastocysts in their first PGD/PGS cycle. Fifty-seven couples had no blastocysts in their PGD/PGS cycles: 43 couples had no blastocysts in one cycle; 10 in two cycles; 4 in three cycles. The non-blastocyst group was older than the blastocyst group (32.37 vs. 30.69, p = 0.048). Anti-mullerian hormone (AMH, ng/ml) in the non-blastocyst group was significantly lower than in the blastocyst group (4.80 ±3.67 vs. 3.07 ±2.30, p = 0.00). Women whose chromosome were aneuploid (47, XXX or 45, X) had a similar AMH level compared with others, but the number of retrieved oocytes was much lower; the normal karyotype was 14.25 and aneuploidy was 5.40 (p = 0.01) in women < 30 years old. There was the same condition in women aged 30–38 years (14.60 vs. 3.44, p < 0.001). Male’s different chromosome karyotype had no influence on double pronuclear number or the rate of blastocyst formation. Presence of endometriosis, polycystic ovary syndrome and tubal factor showed no difference between the blastocyst and non-blastocyst group. Nor did oligospermia and asthenospermia. CONCLUSIONS: Elderly women, those with lower AMH and women with 47, XXX or 45, X have fewer ova, leading to the possibility of no blastocyst. These couples should be fully informed and weigh the advantages and disadvantages before undergoing PGD/PGS.
format Online
Article
Text
id pubmed-6111346
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-61113462018-08-28 What should we focus on before preimplantation genetic diagnosis/screening? Zheng, Zhong Zhao, Xiaoming Xu, Bing Yao, Ning Arch Med Sci Basic Research INTRODUCTION: Preimplantation genetic diagnosis/screening (PGD/PGS) can effectively detect chromosomal abnormalities in an embryo but only if an embryo is available. However, not all couples can obtain an embryo that is available for testing. The purpose of this study was to identify factors which might affect the formation of PGD/PGS embryos to predict the possibility of obtaining embryos that could be detected. MATERIAL AND METHODS: In a retrospective study, we included all couples who underwent PGD/PGS at our center from January 2015 to December 2016. We compared these patients according to the non-blastocyst group and the blastocyst group. RESULTS: There were 302 couples who had blastocysts in their first PGD/PGS cycle. Fifty-seven couples had no blastocysts in their PGD/PGS cycles: 43 couples had no blastocysts in one cycle; 10 in two cycles; 4 in three cycles. The non-blastocyst group was older than the blastocyst group (32.37 vs. 30.69, p = 0.048). Anti-mullerian hormone (AMH, ng/ml) in the non-blastocyst group was significantly lower than in the blastocyst group (4.80 ±3.67 vs. 3.07 ±2.30, p = 0.00). Women whose chromosome were aneuploid (47, XXX or 45, X) had a similar AMH level compared with others, but the number of retrieved oocytes was much lower; the normal karyotype was 14.25 and aneuploidy was 5.40 (p = 0.01) in women < 30 years old. There was the same condition in women aged 30–38 years (14.60 vs. 3.44, p < 0.001). Male’s different chromosome karyotype had no influence on double pronuclear number or the rate of blastocyst formation. Presence of endometriosis, polycystic ovary syndrome and tubal factor showed no difference between the blastocyst and non-blastocyst group. Nor did oligospermia and asthenospermia. CONCLUSIONS: Elderly women, those with lower AMH and women with 47, XXX or 45, X have fewer ova, leading to the possibility of no blastocyst. These couples should be fully informed and weigh the advantages and disadvantages before undergoing PGD/PGS. Termedia Publishing House 2018-01-16 2018-08 /pmc/articles/PMC6111346/ /pubmed/30154896 http://dx.doi.org/10.5114/aoms.2018.72790 Text en Copyright: © 2018 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Basic Research
Zheng, Zhong
Zhao, Xiaoming
Xu, Bing
Yao, Ning
What should we focus on before preimplantation genetic diagnosis/screening?
title What should we focus on before preimplantation genetic diagnosis/screening?
title_full What should we focus on before preimplantation genetic diagnosis/screening?
title_fullStr What should we focus on before preimplantation genetic diagnosis/screening?
title_full_unstemmed What should we focus on before preimplantation genetic diagnosis/screening?
title_short What should we focus on before preimplantation genetic diagnosis/screening?
title_sort what should we focus on before preimplantation genetic diagnosis/screening?
topic Basic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111346/
https://www.ncbi.nlm.nih.gov/pubmed/30154896
http://dx.doi.org/10.5114/aoms.2018.72790
work_keys_str_mv AT zhengzhong whatshouldwefocusonbeforepreimplantationgeneticdiagnosisscreening
AT zhaoxiaoming whatshouldwefocusonbeforepreimplantationgeneticdiagnosisscreening
AT xubing whatshouldwefocusonbeforepreimplantationgeneticdiagnosisscreening
AT yaoning whatshouldwefocusonbeforepreimplantationgeneticdiagnosisscreening